# KANJINTI
> **BLA761073** · Biologics License Application · Sponsor: AMGEN INC · Approved 2019-06-13
## Drug
- **FDA Application Number:** BLA761073
- **Application type:** Biologics License Application
- **Brand name:** KANJINTI
- **Generic name:** TRASTUZUMAB-ANNS
- **Active ingredients:** TRASTUZUMAB-ANNS
- **Dosage form:** VIAL
- **Route:** SINGLE-DOSE
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **Manufacturer:** Amgen, Inc
- **First approval:** 2019-06-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761073)
---
*MORVS · CC0 1.0*